by reprogramming aggressive cancer cells into harmless ... Why Brain Cancer Is Often Resistant to Immunotherapy Feb. 26, 2025 — New findings could help make immunotherapies for brain cancer more ...

including tarlatamab for small cell lung cancer, afamitresgene autoleucel for synovial sarcoma, lifileucel for metastatic melanoma, and tebentafusp for metastatic uveal melanoma. We discuss the ...

A woman who was told she may have a brain tumour due to her severe symptoms is now unrecognisable after losing a jaw-dropping 13 stone. She has transformed her life and even her own family members ...

Once reintroduced back into the body, the T cells replicate, creating a surge of cancer-fighting immune cells. The results of Vitanza’s early-stage clinical trial were published in Nature ...

Their study, published in Nature Communications, reveals how cancer cells disable a built-in "off switch" — and how reactivating it could stop tumor proliferation. Cells function through an intricate ...

Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research, Quebec, Canada (O.B., P.P., E.L.S.). Hypertension and Vascular Research Unit, Lady ...

In addition, genome instability has been long suspected to be the original cause of cell transformation, but whether this applies to most cancer types remains to be determined. Spindle alignment ...

Doctors also sometimes replenish blood cells in cancer patients using healthy blood ... also known as the vascular niche. FLI-1 pushes them into an activated, regenerative state—greatly ...

Belfer Professor in Genetic Medicine at Weill Cornell Medicine Dr. Rafii is also a member of the Englander Institute for Precision Medicine and the Sandra and Edward Meyer Cancer Center at Weill ...

In a new study published in Cell Reports Medicine, they built upon that work to create a universal, small diameter, vascular graft using stem cell-derived arterial endothelial cells (AECs ...